House Dems introduce bill to allow Medicare to negotiate drug prices

House Dems introduce bill to allow Medicare to negotiate drug prices
© Getty Images

House Democrats on Wednesday introduced a bill to allow Medicare to negotiate drug prices, hoping to lay the groundwork for a push on the issue next year.

President TrumpDonald John TrumpLincoln Project ad dubs Jared Kushner the 'Secretary of Failure' Pence: Chief Justice Roberts 'has been a disappointment to conservatives' Twitter bans Trump campaign until it deletes tweet with COVID-19 misinformation MORE previously supported the idea, which is usually associated with Democrats, but did not propose it as part of the drug pricing plan he released in May.

Democrats have attacked Trump for not going far enough to reduce soaring medication costs.

“This bill calls the President's bluff on his drug pricing promises,” said Rep. Lloyd DoggettLloyd Alton DoggettOvernight Health Care: Fauci says family has faced threats | Moderna to charge to a dose for its vaccine | NYC adding checkpoints to enforce quarantine GOP plan would boost deduction for business meals Gilead sets price for five-day coronavirus treatment at ,120 MORE (D-Texas), who is a lead sponsor of the bill along with Reps. Peter WelchPeter Francis WelchVermont has a chance to show how bipartisanship can tackle systemic racism National Retail Federation hosts virtual 'store tours' for lawmakers amid coronavirus Democrats roll out national plan to reopen America MORE (D-Vt.) and Elijah CummingsElijah Eugene CummingsThe Hill's Campaign Report: Biden comes to Washington to honor John Lewis Lawmakers set for tearful goodbye to John Lewis We have 100 days to make our nation right MORE (D-Md.).

Doggett said in an interview that lawmakers are introducing the bill now so that it can be fine-tuned and ready for a push next year if Democrats win back the House in November.

ADVERTISEMENT
We're trying to lay the groundwork for the next session,” he said, saying that Democrats want to be “ready to go with something” to vote on next year.

The measure has over 60 Democratic cosponsors.

The Trump administration has taken several steps on drug pricing already this year. Last week, for example, officials announced they are exploring allowing importation of drugs to increase competition when there are price spikes on old, off-patent drugs, a potentially significant step.

But Democrats want to go farther, and use Medicare’s negotiating power to bring down costs.  

"It defies logic that the federal government is not using its enormous purchasing power to get a better deal for seniors on prescription drugs,” Welch said.